Cystic Fibrosis

Researchers at The University of Texas at Austin have created a new gene-editing technique using bacterial retrons that corrects multiple disease-causing mutations simultaneously. This method targets complex genetic disorders like cystic fibrosis and improves efficiency over traditional tools. The breakthrough, published in Nature Biotechnology, offers hope for more inclusive therapies.